BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Actio Biosciences Announces Preclinical Data Highlighting Ability of ABS-1230 to Potently and Selectively Inhibit KCNT1 and Significantly Reduce Seizure Activity

  December 8, 2025

   · 

  4 min read
• Press Releases

  Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome

  December 8, 2025

   · 

  8 min read
• Press Releases

  SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

  December 8, 2025

   · 

  9 min read
• Press Releases

  Tessel Biosciences Awarded Up To $4.2M Through the ARPA-H CATALYST Program to Advance Drug Safety and ADMET Prediction

  December 8, 2025

   · 

  2 min read
• Press Releases

  PureTech’s Founded Entity Gallop Oncology Announces Positive Initial Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

  December 8, 2025

   · 

  10 min read
• Press Releases

  Feinstein Institutes’ Research Pinpoints Core Cause of Vascular Cognitive Impairment, Unlocking New Therapeutic Avenues for Cognitive Decline

  December 8, 2025

   · 

  3 min read
• Press Releases

  KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

  December 8, 2025

   · 

  3 min read
• Press Releases

  Johnson & Johnson’s INLEXZO™ (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC

  December 8, 2025

   · 

  12 min read
• Press Releases

  ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025

  December 8, 2025

   · 

  4 min read
• Press Releases

  FDA approves Omisirge(R) as First Approved Cell Therapy to Treat Severe Aplastic Anemia

  December 8, 2025

   · 

  3 min read